Long hours of fieldwork and over a decade of analysis in Canadian boreal forests by BIO5 member Betsy Arnold and her team reveal how important fungi are to understand a changing climate.

BIO5 members Vlad Kalinichenko at University of Arizona College of Medicine - Phoenix received a $3 million grant from the National Heart, Lung and Blood Institute (NHLBI) for developing new treatment methods for lung disease in premature infants.

Eight outstanding postdoctoral researchers were awarded the 2024 BIO5 Postdoctoral Fellowship, which aims to propel interdisciplinary researchers to the next stage of their careers.

BIO5 member William D.S. Killgore and his team are developing a small, portable tool to quickly diagnose military personnel with traumatic brain injury (TBI) in the field.

Caroline (Mosley) Bartelme discusses her journey from ponds to policy and how she found a career path that explores the intersection of storytelling and science communication to drive societal impact.

“For every technology or device that my lab pioneered in the field, there is a team of dedicated students,” said BIO5 member DongKyun Kang, UArizona Cancer Center member and associate professor in optical sciences and biomedical engineering.

BIO5 member Michael D.L. Johnson doesn’t miss a beat as a dedicated scientist who inspires the next generation of researchers. He runs a laboratory that examines how bacteria interact with metals during infections, but also has a deep desire to make science accessible to everyone.

A single domino can send things in a new direction, much like how a gene mutation can initiate a chain reaction in cells and lead to cancer. Researchers, including BIO5 member Nirav Merchant, are using big data to target a particularly challenging gene mutation called KRAS.

Dedicated to cancer research, Dr. Martha Dua-Awereh examines the interaction between our immune system and cancer cells in hopes of identifying better treatments.

BIO5 member Deepta Bhattacharya and his team are now a step closer to genetically engineering stem cells that could pave the way for new regenerative medicine treatments for diseases such as Type 1 diabetes.